E-selectin is a transmembrane protein composed of several distinct domains:
E-selectin is transiently expressed on the surface of endothelial cells in response to pro-inflammatory cytokines such as interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α). Its expression peaks around 4 hours after stimulation and declines within 24 hours .
E-selectin plays a pivotal role in the recruitment of leukocytes to sites of inflammation. The process involves several steps:
Recombinant human E-selectin is produced using genetic engineering techniques. The gene encoding E-selectin is inserted into a suitable expression system, such as Chinese Hamster Ovary (CHO) cells, which then produce the protein. The recombinant protein is purified to high levels of purity and can be used for various research and therapeutic applications .
Recombinant human E-selectin is used in several research areas, including: